Home
>
Multimedia
>
Podcasts
>
Stapled Peptides Making Progress

Stapled Peptides Making Progress

September 2, 2010

Gregory L. Verdine, Ph.D., Harvard College Professor and Erving Professor of Chemistry, Department of Cellular and Molecular Biology, Harvard University, and Founder and Co-Chairman, Scientific Advisory Board, Aileron Therapeutics

Podcasts Resources Antibodies (Immune system)Arthritis Biomolecules Cellular, Molecular and Developmental Biology Drug development (Research and development)Genetic Engineering and Biotechnology Immune component Immunology Medicine, Diagnosis, and Therapeutics Monoclonal antibodies Musculoskeletal diseases Nervous system diseases Peptides Protein interactions Proteins Research and development Small molecules Systemic conditions

Share this article on:

Also of Interest

Watching Cancer Proteins in Real Time, with Help from Rare Earth Elements

FDA to Highlight Aging, Longevity Medicine in Planned FARS Updates

Proteomics Maps Eye-Infecting Acanthamoeba Mitochondria Across Oxygen Levels

Talus Bio’s Structure-Free AI Model Targets Unstructured Proteins in Their Native Cellular Context

Designing Peptide Screens to Generate Knowledge, Not Just Hits

Advancing Brain Organoids from Research Models to Scalable Platforms

Related Media

Small Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity, Speed, Scale-Up, and Sustainability

Reporting Live from JPM 2026: Alex Philippidis and Jonathan Grinstein, PhD

AI in Protein Design: Hype vs. Reality Explained by David Baker

Avak Kahvejian, PhD, Recounts His Journey from Sequencing Pioneer to Flagship General Partner on "Close to the Edge"